Axsome Therapeutics AXSM Warrants Issued With Debt Financing
Discontinued — last reported Q4 '23
Warrants Issued With Debt Financing at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept axsm:WarrantsIssuedWithDebtFinancing.
The official record: Axsome Therapeutics’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's warrants issued with debt financing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Axsome Therapeutics's warrants issued with debt financing?
- Axsome Therapeutics (AXSM) reported warrants issued with debt financing of $408.75K in Q4 2023.
- What does warrants issued with debt financing mean?
- Equity warrants granted to lenders as part of a debt financing deal.
- How do you interpret warrants issued with debt financing?
- Frequent use may indicate a higher cost of traditional debt or a need to incentivize lenders in capital-constrained environments.
- How does warrants issued with debt financing compare across companies?
- Common in clinical-stage biopharma companies with limited revenue and higher credit risk profiles.